Removal of a gene protected mice against arterial disease, and they stayed lean even when they ate more. Scientists from Finland developed a mouse model which did not gain weight or develop hardening of arteries, even when they were fed a high-fat diet. The study was published by Science Translational Medicine.
The scientists removed the gene USF1 from mice to determine whether USF1 was good or bad for metabolic health - it was already known that the USF1 gene affects cholesterol and triglyceride levels in humans. When USF1 was removed, the blood lipid profile became beneficial regarding heart disease risk: mice lacking USF1 had low levels of triglycerides and high levels of HDL-cholesterol, the exact opposite of that observed in obese people or diabetics. Lower triglyceride levels were due to their more rapid clearance from the circulation.
The scientists initially intended to focus on lipid levels and arterial disease, but an unexpected discovery changed the course of the research: the researchers found that the mice lacking USF1 stayed lean, even when fed a high-fat diet. Meanwhile, the weight of normal mice was nearly doubled in that period. Scientists began to investigate how such an observation was possible.
The protection against weight-gain was not due to food consumption; the slender USF1-deficient mice ate even more than normal mice. Increase in physical activity did not account for the protection against weight gain, either, because mice lacking USF1 actually moved less. There was no difference in the absorption of nutrients in the intestine.
When the researchers observed that mice lacking USF1 had increased oxygen consumption and carbon dioxide production, they knew they were on the right track - this indicated that the mice had an increased metabolic rate. The driver behind the increased energy expenditure was discovered to be brown fat - whose activity was higher in mice lacking USF1.
The function of the brown fat is to defend the normal body temperature of the mice against cold by burning fat to generate heat. In mice lacking USF1, the brown fat was active even at room temperature and at + 30 ?C (86 ?F) burning fat and sugar molecules. Thus, the higher activity of brown fat protected the mice against weight-gain.
While burning energy nutrients, the brown fat also cleared fats and sugars from the circulation to be burned, acting like an efficient vacuum cleaner. As a result, blood lipid levels improved, and importantly, the arteries of the mice lacking USF1 were protected against vascular disease, having only one fourth of the plaques compared to normal mice.
Finally, the researchers explored whether a small amount of USF1 is also beneficial in humans. By combining Finnish population samples, they discovered a less active form of USF1, and showed that individuals having this genetic variant also had improved blood lipid levels, improved insulin sensitivity, and less blood vessel plaques than the average population.
It has been previously thought that brown adipose tissue is present only in certain mammals, such as mice. However, recent studies have shown that brown fat is also present in humans. As inactivation of USF1 protected the mice against obesity, diabetes, and vascular disease, and as the beneficial effects of low USF1 levels were also shown in humans, the researchers concluded that inhibition of USF1 might be a good strategy to treat cardiovascular disease and diabetes.
https://www.helsinki.fi/en/news/slender-mice-heart-disease-and-diabetes-what-do-they-have-in-common
Edited
Latest News
Why young kids don't get se…
By newseditor
Posted 04 Dec
Phosphatidylinositol 3,5-bi…
By newseditor
Posted 04 Dec
Probiotic-guided CAR-T cell…
By newseditor
Posted 04 Dec
Cell atlases of the human b…
By newseditor
Posted 04 Dec
A sperm-specific transporte…
By newseditor
Posted 02 Dec
Other Top Stories
Bio-mimicry method for preparing and labeling stem cells
Read more
Mice with hyper-long telomeres created!
Read more
Red blood cells from skin fibroblasts!
Read more
New techniques to assess the fate of stem cells in vivo
Read more
cAMP signaling in the generation of hematopoietic stem cells
Read more
Protocols
Cheap, cost-effective, and…
By newseditor
Posted 03 Dec
Temporally multiplexed imag…
By newseditor
Posted 02 Dec
Efficient elimination of ME…
By newseditor
Posted 01 Dec
Personalized drug screening…
By newseditor
Posted 30 Nov
Multi-chamber cardioids unr…
By newseditor
Posted 29 Nov
Publications
Toward low-cost gene therap…
By newseditor
Posted 04 Dec
The bidirectional immune cr…
By newseditor
Posted 04 Dec
Leveraging human immune org…
By newseditor
Posted 04 Dec
Single-cell long-read seque…
By newseditor
Posted 04 Dec
Synapse-specific burst codi…
By newseditor
Posted 04 Dec
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar